Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

FK 463

Known as: FK-463, FK463 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
A new spectrum of human fungal infections is increasing due to increased cancer, AIDS, and immunocompromised patients. The… 
Highly Cited
2006
Highly Cited
2006
Summary Background Micafungin (FK463) is a new lipopeptide… 
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2005
Highly Cited
2005
ABSTRACT Micafungin (FK463) is a new parenteral echinocandin. A multicenter, phase I, open-label, sequential-group dose… 
Highly Cited
2004
Highly Cited
2004
The efficacy and safety of micafungin (FK463), which is a new lipopeptide antifungal agent of the echinocandin class and is… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT We evaluated the in vitro activity of the new echinocandin antifungal micafungin against Candida spp. using… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT Micafungin (FK463) is an echinocandin that demonstrates potent in vitro antifungal activities against Candida and… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT The in vitro antifungal activity and spectrum of FK463 were compared with those of amphotericin B, fluconazole, and… 
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2000
Highly Cited
2000
ABSTRACT The efficacy of intravenous injection of FK463, a novel water-soluble lipopeptide, was evaluated in mouse models of… 
Review
2000
Review
2000
Development of new approaches for treatment of invasive fungal infections encompasses new delivery systems for approved and… 
Highly Cited
1999